BioCentury
ARTICLE | Clinical News

Amlexanox: To begin Phase III trial

April 26, 1993 7:00 AM UTC

Chemex Pharmaceuticals Inc. (CHMX) Product: Amlexanox, an anti-allergic agent Indication: Canker sores Status: To begin Phase III trial Note: Product is a joint venture with Block Drug ...